Different Placebos, Different Mechanisms, Different Outcomes: Lessons for Clinical Trials
Fabrizio Benedetti, Sara Dogue, Fabrizio Benedetti, Sara Dogue
Abstract
Clinical trials use placebos with the assumption that they are inert, thus all placebos are considered to be equal. Here we show that this assumption is wrong and that different placebo procedures are associated to different therapeutic rituals which, in turn, trigger different mechanisms and produce different therapeutic outcomes. We studied high altitude, or hypobaric hypoxia, headache, in which two different placebos were administered. The first was placebo oxygen inhaled through a mask, whereas the second was placebo aspirin swallowed with a pill. Both placebos were given after a conditioning procedure, whereby either real oxygen or real aspirin was administered for three consecutive sessions to reduce headache pain. We found that after real oxygen conditioning, placebo oxygen induced pain relief along with a reduction in ventilation, blood alkalosis and salivary prostaglandin (PG)E2, yet without any increase in blood oxygen saturation (SO2). By contrast, after real aspirin conditioning, placebo aspirin induced pain relief through the inhibition of all the products of cyclooxygenase, that is, PGD2, PGE2, PGF2, PGI2, thromboxane (TX)A2, without affecting ventilation and blood alkalosis. Therefore, two different placebos, associated to two different therapeutic rituals, used two different pathways to reduce headache pain. The analgesic effect following placebo oxygen was superior to placebo aspirin. These findings show that different placebos may use different mechanisms to reduce high altitude headache, depending on the therapeutic ritual and the route of administration. In clinical trials, placebos and outcome measures should be selected very carefully in order not to incur in wrong interpretations.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- De Craen AJM, Tijssen JGP, de Gans J, Kleijnen J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol 2000;247:183–88.
- Bannuru RR, McAlindon TE, Sullivan MC, Wong JB, Kent DM, Schmid CH. Effectiveness and implications of alternative placebo treatments: a systematic review and network metaanalysis of osteoarthritis trials. Ann Intern Med 2015;163:365–72. 10.7326/M15-0623
- Benedetti F. Placebo and the new physiology of the doctor-patient relationship. Physiol Rev 2013;93:1207–46. 10.1152/physrev.00043.2012
- Benedetti F. Placebo effects: from the neurobiological paradigm to translational implications. Neuron 2014;84:623–37. 10.1016/j.neuron.2014.10.023
- Kong J, Spaeth R, Cook A, Kirsch I, Claggett B, Vangel M, et al. Are all placebo effects equal? Placebo pills, sham acupuncture, cue conditioning and their association. PLoS One 2013;8:e67485 10.1371/journal.pone.0067485
- Benedetti F, Durando J, Giudetti L, Pampallona A, Vighetti S. High altitude headache: the effects of real versus sham oxygen administration. Pain 2015, July 7, Epub ahead of print, in press.
- Benedetti F, Durando J, Vighetti S. Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway. Pain 2014;155:921–28. 10.1016/j.pain.2014.01.016
- Sutton JR, Coates G, Houston CS, Hackett PH, Oelz O. The Lake Louise consensus on the definition and quantification of altitude illness In: Sutton JR, Coates G, Houston CS eds. Hypoxia and mountain medicine. Burlington, Vermont: Queen City Printers, 1992: 327–30.
- Imray C, Wright A, Subudhi A, Roach R. Acute mountain sickness: pathophysiology, prevention and treatment. Prog Cardiovasc Dis 2010;52:467–84. 10.1016/j.pcad.2010.02.003
- Wilson MH, Newman S, Imray CS. The cerebral effects of ascent to high altitudes. Lancet Neurol 2009;8:175–91. 10.1016/S1474-4422(09)70014-6
- Richalet J-P, Hornych A, Rathat C, Aumont J, Larmignat P, Rémy P. Plasma prostaglandins, leukotrienes and thromboxane in acute high altitude hypoxia. Resp Physiol 1991;85: 205–15.
- Busse R, Fosterman U, Matsuda H, Pohl U. The role of prostaglandins in the endotheliummediate vasodilatory response to hypoxia. Pflüg Arch 1984;401:77–83.
- Davis RJ, Murdoch CE, Ali M, Purbrick S, Ravid R, Baxter GS, et al. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br J Pharmacol 2004;141:580–85.
- Fredricks KT, Liu Y, Rusch NJ, Lombard JH. Role of endothelium and arterial K+ channels in mediating hypoxic dilation of middle cerebral arteries. Am J Physiol 1994;267:H580–86.
- Messina EJ, Sun D, Koller A, Wolin MS, Kaley G. Role of endothelium-derived prostaglandins in hypoxia-elicited arteriolar dilation in rat skeletal muscle. Circulation Res 1992;71:790–96.
- Ray CJ, Abbas MR, Coney AM, Marshall JM. Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: in vivo and in vitro studies. J Physiol 2002;544:195–209.
- Kawabata A. Prostaglandin E2 and pain—An update. Biol Pharm Bull 2011;34: 1170–73.
- West JB. The Physiologic Basis of High-Altitude Diseases. Ann Intern Med 2004;141:789–800.
- Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol 2007;102:1313–22.
- Bartsch P, Baumgartner RW, Waber U, Maggiorini M, Oelz O. Comparison of carbondioxide- enriched, oxygen-enriched, and normal air in treatment of acute mountain sickness. Lancet 1990;336:772–75.
- Burtscher M, Likar R, Nachbauer W, Philadelphy M. Aspirin for prophylaxis against headache at high altitudes: randomised, double blind, placebo controlled trial. Br Med J 1998;316:1057–58.
- Rosenthal TB. Effect of temperature on the pH of blood and plasma in vitro. J Biol Chem 1948;173:25–30.
- Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific sub-systems. J Neurosci 1999;19:484–94.
- Benedetti F, Amanzio M, Rosato R, Blanchard C. Non-opioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nature Med 2011;17:1228–30. 10.1038/nm.2435
- Baretella O, Xu A, Vanhoutte PM. Acidosis prevents and alkalosis augments endothelium dependent contractions in mouse arteries. Pflugers Arch 2014;466:295–305. 10.1007/s00424-013-1323-z
- Gordon JB, VanderHeyden MA, Halla TR, Cortez EP, Hernandez G, Haworth ST, et al. What leads to different mediators of alkalosis-induced vasodilation in isolated and in situ pulmonary vessels? AM J Physiol Lung Cell Mol Physiol 2003;284:L799–807.
- Hella TR, Madden JA, Gordon JB. Mediators of alkalosis-induced relaxation of piglet pulmonary veins. Am J Physiol Lung Cell Mol Physiol 2000;278:L968–73.
- Ishii Y, Kitamura S. Hyperventilation stimulates the release of prostaglandins I2 and E2 from lung in humans. Prostaglandins 1990;39:685–91.
- Benedetti F, Amanzio M, Baldi S, Casadio C, Cavallo A, Mancuso M, et al. The specific effects of prior opioid exposure on placebo analgesia and placebo respiratory depression. Pain 1998;75:313–19.
- Benedetti F, Amanzio M, Baldi S, Casadio C, Maggi G. Inducing placebo respiratory depressant responses in humans via opioid receptors. Eur J Neurosci 1998;11: 625–31.
- Fogan L. Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation. Arch Neurol 1985:42:362–63.
- Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA 2009;302:2451–57. 10.1001/jama.2009.1855
Source: PubMed